Kimberly-Clark/$KMB

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Kimberly-Clark

With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It intends to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.

Ticker

$KMB
Primary listing

Employees

38,000

Kimberly-Clark Metrics

BasicAdvanced
$34B
17.57
$5.91
0.31
$5.00
4.85%

What the Analysts think about Kimberly-Clark

Analyst ratings (Buy, Hold, Sell) for Kimberly-Clark stock.

Bulls say / Bears say

Kimberly-Clark posted its strongest volume-driven organic sales growth in five years, with a 3.9% rise in Q2 2025, led by a 5% jump in volumes that lifted its outlook for full-year profits (Reuters)
The company agreed to sell a 51% stake in its international tissue business to Suzano for $3.4 billion, receiving $1.73 billion in cash, which will allow it to refocus on higher-margin personal care businesses and return capital to shareholders (Reuters)
Assets placed in the international tissue joint venture generated $500 million in EBITDA from $3.3 billion of sales in 2024, highlighting the value-creation potential of the sale (FT)
Despite beating Q3 sales estimates, gross margins contracted by 170 basis points year-over-year due to U.S. tariffs and pricing investments, underlining continued margin pressure (Reuters)
Management revised its 2025 organic sales growth target to match the broader industry average of about 2%, down from its earlier goal to outpace the market, reflecting softer demand expectations (Reuters)
Global trade policy uncertainty is forcing Kimberly-Clark to raise prices or cut earnings guidance, heightening uncertainty around consumer demand and cost recovery strategies (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 2 Nov 2025.

Kimberly-Clark Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Kimberly-Clark Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $KMB

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs